ADRENORECEPTORS BLOCKING: RECENT DATA ON URAPIDIL USAGE
https://doi.org/10.15829/1560-4071-2015-9-103-106
Abstract
The article is focused on recent (last two years) data from the trials of alphaadrenoblocker urapidil as a drug of choice for severe refractory hypertension, for controlled hypotension, and for outpatient care as part of combination therapy.
About the Authors
O. Yu. Shaydyuk
Russian National Research Medical University named after N.I. Pirogov, Moscow
Russian Federation
Russian Federation
E. O. Taratukhin
Russian National Research Medical University named after N.I. Pirogov, Moscow
Russian Federation
Russian Federation
References
1. Chobanyan-Jürgens K, Jordan J. Electrical carotid sinus stimulation: chances and challenges in the management of treatment resistant arterial hypertension. Curr Hypertens Rep, 2015; 17: 587.
2. Hannawi B, Ibrahim H, Baker CM. Renal denervation: past, present and future. Rev Cardiovasc Med, 2015; 16: 114-24.
3. Petràk O, Zelinka T, Štrauch B, et al. Combination antihypertensive therapy in clinical practice. The analysis of 1254 consecutive patients with uncontrolled hypertension. Journal of Hum Hypert, 2015; doi:10.1038/jhh.2014.24.
4. Li K, Li Y, Yang L, et al. Sensitive determination of urapidil at an electrochemically pretreated glassy carbon electrode by linear sweep voltammetry. Analyt Meth, 2014; 6: 6548-54.
5. Saxena A, Gupta AK, Praveen K, et al. Quantification of urapidil in human plasma using ultra performance liquid chromatography — electrospray ionization mass spectrometry for pharmacokinetic study in healthy indian volunteers. Int J Pharm and Pharm Sc, 2014; 6: 565-70.
6. Wu KS, Zhou JC, Li HY et al. Antihypertensive therapy with nicardipine for patients with aortic disease is associated with more esmolol usage than urapidil. J Thorac Dis, 2014; 6: 1765-71.
7. Diemunsch P, Garcia V, Lyons G, et al. Urapidil versus nicardipine in preeclamptic toxaemia: a randomised feasibility study. EJA, 2015; 32: 1-2.
8. Kutlesič MS, Kutlesič RM, Koratevič GP. Posterior reversible encephalopathy syndrome in eclamptic patients: neuroradiological manifestation, pathogenesis and management. Med Pregl, 2015; 68: 53-8.
9. Stocks G. Preeclampsia: pathophysiology, old and new strategies for management. EJA, 2014; 31: 183-9.
10. Yang W, Zhou YJ, Fu Y, et al. A multicenter, randomized, trial comparing urapidil and nitroglycerin in multifactor heart failure in the elderly. Am J Med Sci, 2015; July 7.
11. Chaundary SS, Patel HK, Parejiya PB, et al. chronomodulated drug delivery system of urapidil for the treatment of hypertension. Int J Pharm Investig, 2015; 5(2): 107-13.
12. Minushkina LO. Treatment of hypertensive emergencies and malignant hypertension: the possibility of using urapidil. Kardiologiia, 2014; 54: 70-4. Russian (Минушкина Л. О. Лечение гипертонических кризов и злокачественной гипертонии: возможности применения урапидила. Кардиология, 2014; 54: 70-4).
13. Shaydyuk OYu, Taratukhin EO. Sympathetic activity and arterial hypertension: potential for correction. Russ J Cardiol, 2013; 2: 61-4. Russian (Шайдюк О. Ю., Таратухин Е. О. Симпатическая активность и артериальная гипертония: возможности коррекции. Росийский кардиологический журнал, 2013; 2: 61-4).
14. Wang F, Chen B, Liu Y, et al. Effect of urapidil combined with phentolamine on hypertension during extracorporeal circulation. Nan Fang Yi Ke Da Xue Xue Bao, 2014; 34: 1342-6.
15. Wand D, Wang Z, Lou N. Efficacy of urapidil, nifedipine and nitroglycerin for the treatment of postoperative hypertension after tumorectomy. Chin J Emerg Med, 2014; 23: 335-9.
16. Gaponova NI, Abdrakhmanov VR, Kadyshev VA, et al. Combined action antihypertensive agent urapidil: effectiveness and safety in clinical practice. Cardiovascular Therapy and Prevention, 2014; 13(1): 57-63. Russian (Гапонова Н. И. Абдрахманов В.Р., Кадышев В.А. и др. Антигипертензивный препарат комбинированного действия урапидил: эффективность и безопасность применения в клинической практике. Кардиоваскулярная терапия и профилактика, 2014; 13(1): 57-63).
Review
For citations:
Shaydyuk O.Yu., Taratukhin E.O. ADRENORECEPTORS BLOCKING: RECENT DATA ON URAPIDIL USAGE. Russian Journal of Cardiology. 2015;(9):103-106. (In Russ.) https://doi.org/10.15829/1560-4071-2015-9-103-106
Views:
672
Email this article 